HUTCHMED (China) Ltd (HCM) Price Prediction & ForecastHCMHUTCHMED (China) Ltd

Alphio's HCM stock price prediction model matches the current HUTCHMED (China) Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $12.44 (+0.50%). The 1-week path is $12.44 (+0.48%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

HUTCHMED (China) Ltd is a good buy right now, primarily driven by its recent conditional approval for Fanregratinib, which is expected to enhance revenue growth. The current price is $12.38, and the forward P/E ratio is 14.41, indicating a more favorable valuation compared to its historical performance. Additionally, the stock has shown a 20-day change of +11.23%, suggesting positive momentum. However, the main risk is its high P/E ratio of 1103.79, which indicates potential overvaluation if future earnings do not meet expectations.

HUTCHMED (China) Ltd (HCM) last closed at $12.38, losing -0.28%. These facts feed the 1-day and 1-week HCM price prediction above.